{
    "id": "0332",
    "question": "A 55-year-old man presents to the emergency department with complaints of nausea, vomiting, palpitations, and dizziness, which have lasted for the past 3 hours. He was diagnosed with heart failure 1 year ago. During his last visit to his primary care physician, he was doing well and the lab results were normal. He reports that he has been taking low-dose aspirin and digoxin regularly for 1 year, and verapamil was recently added to prevent his frequent migraine headaches. An electrocardiogram is performed urgently and shows paroxysmal atrial tachycardia with block. Suspecting digitalis toxicity, the emergency medicine physician sends blood to the lab for a serum digoxin level, which is 3.7 ng/mL (therapeutic range: 0.8\u20132 ng/mL). Which of the following mechanisms most likely explains the development of digitalis toxicity in this patient?",
    "options": {
        "A": "Drug-induced hypokalemia",
        "B": "Increased intestinal absorption of digoxin",
        "C": "Inhibition of CYP 3A4 isoenzyme",
        "D": "Inhibition of P-glycoprotein"
    },
    "answer": "D",
    "predict": "{\"step_by_step_thinking\": \"To approach this question, we need to consider the factors that contribute to digitalis toxicity. Digitalis toxicity occurs when the concentration of digoxin exceeds the therapeutic range, which can lead to symptoms such as nausea, vomiting, palpitations, and dizziness, as seen in this patient. Let's evaluate each option: Option A, drug-induced hypokalemia, is a known risk factor for digitalis toxicity. Low potassium levels can increase the risk of digitalis toxicity by increasing the force of cardiac contractions and the rate of atrioventricular conduction. However, there is no mention of the patient having any electrolyte imbalances or medications that could cause hypokalemia. Option B, increased intestinal absorption of digoxin, is not a common mechanism for digitalis toxicity. While changes in gastrointestinal motility or absorption can affect digoxin levels, there is no indication in the patient's history that would suggest this as the cause of toxicity. Option C, inhibition of CYP 3A4 isoenzyme, is not a relevant mechanism for digitalis toxicity. Digoxin is primarily metabolized by the liver, and its metabolism is not significantly affected by CYP 3A4 inhibitors. Option D, inhibition of P-glycoprotein, is a relevant mechanism for digitalis toxicity. P-glycoprotein is a protein that can bind to digoxin, reducing its absorption and increasing its clearance. Verapamil, the patient's recent addition for migraine headaches, is a known P-glycoprotein inhibitor. This can lead to increased levels of digoxin, potentially causing toxicity. Given the patient's recent initiation of verapamil and the symptoms of digitalis toxicity, the most likely explanation is the inhibition of P-glycoprotein, leading to increased digoxin levels.\"} \"answer_choice\": \"D\"",
    "snippets": [],
    "scores": [],
    "execution_time": 39.60961723327637
}